Evaluation of Galectin3 levels in psoriatic patients treated by narrow-band UVB phototherapy

Background: Psoriasis-specific proteins dysregulated in keratinocytes and involved in the pathophysiological process of psoriasis remains elusive. Objective: This study aimed to investigate the serum and tissue levels of Galectin3 in patients with psoriasis vulgaris before and after narrow-band ultr...

Full description

Bibliographic Details
Main Authors: Mohamed H. Khater, Sukina AbdallaAlhabib, Kamal A. Elkshishy, Fathia M. Khattab
Format: Article
Language:English
Published: Taylor & Francis Group 2020-11-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:http://dx.doi.org/10.1080/09546634.2019.1670778
_version_ 1797683649668186112
author Mohamed H. Khater
Sukina AbdallaAlhabib
Kamal A. Elkshishy
Fathia M. Khattab
author_facet Mohamed H. Khater
Sukina AbdallaAlhabib
Kamal A. Elkshishy
Fathia M. Khattab
author_sort Mohamed H. Khater
collection DOAJ
description Background: Psoriasis-specific proteins dysregulated in keratinocytes and involved in the pathophysiological process of psoriasis remains elusive. Objective: This study aimed to investigate the serum and tissue levels of Galectin3 in patients with psoriasis vulgaris before and after narrow-band ultraviolet B (NB-UVB) phototherapy. Methods: This study was designed as a cross-sectional case-control. This study included 30 patients with psoriasis Vulgaris and 20 healthy individuals. Psoriasis Area and Severity Index (PASI) score were used to evaluate the patients with psoriasis Vulgaris before and after treatment. All patients were treated two times per week for 3 months with NB-UVB phototherapy. Enzyme-linked immunosorbent assay (ELISA) was used to assess serum levels of galectin 3 of the healthy control subjects and psoriatic patients before and after treatment by NB-UVB phototherapy. Results: The serum level of galectin 3 was significantly lower in patients with psoriasis Vulgaris versus healthy control subjects (p value < .001). There was a significant increase in the serum levels of Galectin 3 and decrease in PASI scores after 3 months of treatment with NB-UVB phototherapy in patients with psoriasis Vulgaris (p value < .001). Conclusions: This study concluded that NB-UVB phototherapy for 3 months in patients with psoriasis Vulgaris was an essential method for decreasing PASI scores and an increase in the serum levels of galectin 3.
first_indexed 2024-03-12T00:17:37Z
format Article
id doaj.art-0010f3996f5344ae87eef4e23f7febd0
institution Directory Open Access Journal
issn 0954-6634
1471-1753
language English
last_indexed 2024-03-12T00:17:37Z
publishDate 2020-11-01
publisher Taylor & Francis Group
record_format Article
series Journal of Dermatological Treatment
spelling doaj.art-0010f3996f5344ae87eef4e23f7febd02023-09-15T14:23:03ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532020-11-0131875876210.1080/09546634.2019.16707781670778Evaluation of Galectin3 levels in psoriatic patients treated by narrow-band UVB phototherapyMohamed H. Khater0Sukina AbdallaAlhabib1Kamal A. Elkshishy2Fathia M. Khattab3Zagazig UniversityBenghazi UniversityZagazig UniversityZagazig UniversityBackground: Psoriasis-specific proteins dysregulated in keratinocytes and involved in the pathophysiological process of psoriasis remains elusive. Objective: This study aimed to investigate the serum and tissue levels of Galectin3 in patients with psoriasis vulgaris before and after narrow-band ultraviolet B (NB-UVB) phototherapy. Methods: This study was designed as a cross-sectional case-control. This study included 30 patients with psoriasis Vulgaris and 20 healthy individuals. Psoriasis Area and Severity Index (PASI) score were used to evaluate the patients with psoriasis Vulgaris before and after treatment. All patients were treated two times per week for 3 months with NB-UVB phototherapy. Enzyme-linked immunosorbent assay (ELISA) was used to assess serum levels of galectin 3 of the healthy control subjects and psoriatic patients before and after treatment by NB-UVB phototherapy. Results: The serum level of galectin 3 was significantly lower in patients with psoriasis Vulgaris versus healthy control subjects (p value < .001). There was a significant increase in the serum levels of Galectin 3 and decrease in PASI scores after 3 months of treatment with NB-UVB phototherapy in patients with psoriasis Vulgaris (p value < .001). Conclusions: This study concluded that NB-UVB phototherapy for 3 months in patients with psoriasis Vulgaris was an essential method for decreasing PASI scores and an increase in the serum levels of galectin 3.http://dx.doi.org/10.1080/09546634.2019.1670778nb-uvb phototherapypasi scorepsoriasisgalectin 3
spellingShingle Mohamed H. Khater
Sukina AbdallaAlhabib
Kamal A. Elkshishy
Fathia M. Khattab
Evaluation of Galectin3 levels in psoriatic patients treated by narrow-band UVB phototherapy
Journal of Dermatological Treatment
nb-uvb phototherapy
pasi score
psoriasis
galectin 3
title Evaluation of Galectin3 levels in psoriatic patients treated by narrow-band UVB phototherapy
title_full Evaluation of Galectin3 levels in psoriatic patients treated by narrow-band UVB phototherapy
title_fullStr Evaluation of Galectin3 levels in psoriatic patients treated by narrow-band UVB phototherapy
title_full_unstemmed Evaluation of Galectin3 levels in psoriatic patients treated by narrow-band UVB phototherapy
title_short Evaluation of Galectin3 levels in psoriatic patients treated by narrow-band UVB phototherapy
title_sort evaluation of galectin3 levels in psoriatic patients treated by narrow band uvb phototherapy
topic nb-uvb phototherapy
pasi score
psoriasis
galectin 3
url http://dx.doi.org/10.1080/09546634.2019.1670778
work_keys_str_mv AT mohamedhkhater evaluationofgalectin3levelsinpsoriaticpatientstreatedbynarrowbanduvbphototherapy
AT sukinaabdallaalhabib evaluationofgalectin3levelsinpsoriaticpatientstreatedbynarrowbanduvbphototherapy
AT kamalaelkshishy evaluationofgalectin3levelsinpsoriaticpatientstreatedbynarrowbanduvbphototherapy
AT fathiamkhattab evaluationofgalectin3levelsinpsoriaticpatientstreatedbynarrowbanduvbphototherapy